HRP20120138T1 - Energetski dodatak prehrani za skeletne mišiće i za zaštitu kardiovaskularnog sustava - Google Patents
Energetski dodatak prehrani za skeletne mišiće i za zaštitu kardiovaskularnog sustava Download PDFInfo
- Publication number
- HRP20120138T1 HRP20120138T1 HRP20120138TT HRP20120138T HRP20120138T1 HR P20120138 T1 HRP20120138 T1 HR P20120138T1 HR P20120138T T HRP20120138T T HR P20120138TT HR P20120138 T HRP20120138 T HR P20120138T HR P20120138 T1 HRP20120138 T1 HR P20120138T1
- Authority
- HR
- Croatia
- Prior art keywords
- carnitine
- dietary supplement
- acid
- group
- mixtures
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract 11
- 210000002027 skeletal muscle Anatomy 0.000 title claims 3
- 230000002526 effect on cardiovascular system Effects 0.000 title 1
- 229960004203 carnitine Drugs 0.000 claims abstract 13
- 150000003839 salts Chemical class 0.000 claims abstract 9
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims abstract 8
- 239000000203 mixture Substances 0.000 claims abstract 6
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract 4
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 claims abstract 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract 4
- 229960003624 creatine Drugs 0.000 claims abstract 4
- 239000006046 creatine Substances 0.000 claims abstract 4
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims abstract 3
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract 3
- 229940110767 coenzyme Q10 Drugs 0.000 claims abstract 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract 3
- 239000011707 mineral Substances 0.000 claims abstract 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000004480 active ingredient Substances 0.000 claims abstract 2
- 229940024606 amino acid Drugs 0.000 claims abstract 2
- 150000001413 amino acids Chemical class 0.000 claims abstract 2
- 229960000310 isoleucine Drugs 0.000 claims abstract 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract 2
- 229940055726 pantothenic acid Drugs 0.000 claims abstract 2
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract 2
- 239000011713 pantothenic acid Substances 0.000 claims abstract 2
- 229950007002 phosphocreatine Drugs 0.000 claims abstract 2
- 229960002477 riboflavin Drugs 0.000 claims abstract 2
- 235000019192 riboflavin Nutrition 0.000 claims abstract 2
- 239000002151 riboflavin Substances 0.000 claims abstract 2
- 239000004474 valine Substances 0.000 claims abstract 2
- 239000002253 acid Substances 0.000 claims 7
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 2
- 229940009098 aspartate Drugs 0.000 claims 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 235000010755 mineral Nutrition 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 2
- NDVRKEKNSBMTAX-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O NDVRKEKNSBMTAX-BTVCFUMJSA-N 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 1
- MOWWSILJZYQYQJ-UHFFFAOYSA-N C(C(=O)O)(=O)O.C(C1=CC(=O)NC(=O)N1)(=O)O Chemical compound C(C(=O)O)(=O)O.C(C1=CC(=O)NC(=O)N1)(=O)O MOWWSILJZYQYQJ-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims 1
- 239000001527 calcium lactate Substances 0.000 claims 1
- 229960002401 calcium lactate Drugs 0.000 claims 1
- 235000011086 calcium lactate Nutrition 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 235000019262 disodium citrate Nutrition 0.000 claims 1
- 239000002526 disodium citrate Substances 0.000 claims 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 1
- 229960001518 levocarnitine Drugs 0.000 claims 1
- 239000007937 lozenge Substances 0.000 claims 1
- YZURQOBSFRVSEB-UHFFFAOYSA-L magnesium;2-aminoethanesulfonate Chemical compound [Mg+2].NCCS([O-])(=O)=O.NCCS([O-])(=O)=O YZURQOBSFRVSEB-UHFFFAOYSA-L 0.000 claims 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims 1
- 235000019796 monopotassium phosphate Nutrition 0.000 claims 1
- 229940023136 pantothenic acid 10 mg Drugs 0.000 claims 1
- 230000037081 physical activity Effects 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims 1
- 229940047034 riboflavin 5 mg Drugs 0.000 claims 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 claims 1
- 238000005728 strengthening Methods 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 229940095064 tartrate Drugs 0.000 claims 1
- 229940066528 trichloroacetate Drugs 0.000 claims 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Dodatak prehrani, naznačen time što sadrži:- kao aktivne sastojke, kombinaciju pomiješanih ili odvojeno pakiranih: a) propionil-1-karnitina ili njegove farmakološki prihvatljive soli i izborno karnitin, kojeg se bira iz skupine koju čine L-karnitin, acetil-1-karnitin, valeril-1-karnitin, izovaleril-1-karnitin i butiril-1-karnitin, ili njihove farmakološki prihvatljive soli ili njihove smjese; b) koenzim Q10;c) riboflavin; d) pantotenska kiselina; i- slijedeće izborne komponente: f) aminokiselina, koju se bira iz skupine koju čine valin, leucin, izoleucin ili njihove smjese; g) kreatin, kojeg se bira iz skupine koju čine kreatin i fosfokreatin ili njihove smjese; ih) mineralna sol. Patent sadrži još 8 patentnih zahtjeva.
Claims (9)
1. Dodatak prehrani, naznačen time što sadrži:
– kao aktivne sastojke, kombinaciju pomiješanih ili odvojeno pakiranih:
a) propionil-1-karnitina ili njegove farmakološki prihvatljive soli i izborno karnitin, kojeg se bira iz skupine koju čine l-karnitin, acetil-1-karnitin, valeril-1-karnitin, izovaleril-1-karnitin i butiril-1-karnitin, ili njihove farmakološki prihvatljive soli ili njihove smjese;
b) koenzim Q10;
c) riboflavin;
d) pantotenska kiselina; i
– slijedeće izborne komponente:
f) aminokiselina, koju se bira iz skupine koju čine valin, leucin, izoleucin ili njihove smjese;
g) kreatin, kojeg se bira iz skupine koju čine kreatin i fosfokreatin ili njihove smjese; i
h) mineralna sol.
2. Dodatak prehrani u skladu s patentnim zahtjevom 1, naznačen time što se farmakološki prihvatljivu sol bira iz skupine koju čine: klorid; bromid; jodid; aspartat, kiseli aspartat; citrat, kiseli citrat; fosfat, kiseli fosfat; fumarat, kiseli fumarat; glicerofosfat; glukozni fosfat; laktat; maleat, kiseli maleat; mukat; orotat; oksalat; kiseli oksalat; sulfat, kiseli sulfat; tartarat; trikloracetat; trifluoracetat i metansulfonat.
3. Dodatak prehrani u skladu s patentnim zahtjevom 1, naznačen time što se mineralnu sol (h) bira iz skupine koju čine: dinatrijev citrat, monokalijev fosfat, kalcijev laktat i magnezijev taurat.
4. Dodatak prehrani u skladu s patentnim zahtjevom 1, naznačen time što se težinski omjer (a):(b):(c):(d) kreće od 10:0,04:0,08:0,4 to 1:4:4:20.
5. Dodatak prehrani u skladu s patentnim zahtjevom 4, naznačen time što se težinski omjer (a):(b):(c):(d) kreće od 10:2:2:2 do 1:1:1:5.
6. Dodatak prehrani u skladu s patentnim zahtjevom 1, naznačen time što je u obliku tableta, lozengeta, pilula, kapsula i granulata.
7. Dodatak prehrani u skladu s patentnim zahtjevom 6, koji je u obliku jedinice doziranja, naznačen time što sadrži:
propionil-1-karnitin 50 mg do 2.000 mg
koenzim Q10 5 mg do 200 mg
riboflavin 5 mg do 200 mg
pantotenska kiselina 10 mg do 1.000 mg.
8. Postupak povećavanja sposobnosti skeletnih mišića da održavaju dulje periode intenzivne fizičke aktivnosti, naznačen time što se sastoji u primjeni dodatka prehrani u skladu s bilo kojim od patentnih zahtjeva 1 do 7.
9. Postupak osiguravanja energije i jačanja skeletnih mišića, naznačen time što se sastoji u primjeni dodatka prehrani u skladu s bilo kojim od patentnih zahtjeva 1 do 7.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/253,806 US8252309B2 (en) | 2000-04-04 | 2005-10-20 | Dietary supplement energy-providing to skeletal muscles |
| PCT/EP2006/066538 WO2007045533A1 (en) | 2005-10-20 | 2006-09-20 | Dietary supplement energy-providing to skeletal muscles and protecting the cardio vascular tract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20120138T1 true HRP20120138T1 (hr) | 2012-05-31 |
Family
ID=37479888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20120138TT HRP20120138T1 (hr) | 2005-10-20 | 2012-02-10 | Energetski dodatak prehrani za skeletne mišiće i za zaštitu kardiovaskularnog sustava |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8252309B2 (hr) |
| EP (1) | EP1940251B1 (hr) |
| JP (1) | JP2009512430A (hr) |
| CN (1) | CN101291599A (hr) |
| AR (1) | AR056129A1 (hr) |
| AT (1) | ATE535159T1 (hr) |
| AU (1) | AU2006303417A1 (hr) |
| BR (1) | BRPI0617487A2 (hr) |
| CA (1) | CA2622555A1 (hr) |
| CY (1) | CY1112660T1 (hr) |
| DK (1) | DK1940251T3 (hr) |
| ES (1) | ES2378655T3 (hr) |
| HR (1) | HRP20120138T1 (hr) |
| PL (1) | PL1940251T3 (hr) |
| PT (1) | PT1940251E (hr) |
| RS (1) | RS52129B (hr) |
| SI (1) | SI1940251T1 (hr) |
| TW (1) | TW200803761A (hr) |
| WO (1) | WO2007045533A1 (hr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7479120B2 (en) * | 2002-02-22 | 2009-01-20 | Hans Gregersen | Method and apparatus for investigating force-deformation properties in muscles in walls of bodily hollow systems |
| CN103415532B (zh) | 2011-01-20 | 2016-05-04 | 万德-生物技术及制药有限公司 | 抗氧化、抗炎、抗辐射、金属螯合的化合物及其用途 |
| JP2014131961A (ja) * | 2011-04-08 | 2014-07-17 | Mitsubishi Gas Chemical Co Inc | 動物用栄養組成物 |
| WO2014016831A1 (en) | 2012-07-23 | 2014-01-30 | Oneday - Biotech And Pharma Ltd. | Glutathione-elevating compositions and uses thereof |
| EP2877194A4 (en) | 2012-07-25 | 2016-03-16 | Oneday Biotech And Pharma Ltd | Compositions and methods for increasing carnitine concentration in muscle tissue |
| US9327005B1 (en) | 2012-11-15 | 2016-05-03 | Vdf Futureceuticals, Inc. | Compositions and methods for improved energy metabolism |
| KR101636946B1 (ko) * | 2013-07-29 | 2016-07-06 | 한국생명공학연구원 | 오로트산을 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물 |
| EP3368498A4 (en) | 2015-10-27 | 2019-06-12 | Cytozyme Animal Nutrition, Inc. | ANIMAL NUTRITIONAL COMPOSITIONS AND RELATED METHODS |
| US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
| AU2019261476B2 (en) | 2018-04-25 | 2021-11-18 | Oncocross Co.,Ltd. | Composition for preventing and treating muscular disease |
| CN112535294A (zh) * | 2020-11-24 | 2021-03-23 | 苏州麦轮生物科技有限公司 | 牛磺酸镁在制备改善心血管健康的营养补充剂中的应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3219454A (en) | 1961-06-15 | 1965-11-23 | Borden Co | Low calorie diet |
| US3689641A (en) | 1970-08-20 | 1972-09-05 | Merck & Co Inc | Concentrated water suspension of nutrients |
| US4237118A (en) | 1972-03-06 | 1980-12-02 | Howard Alan N | Dietary supplement and dietary methods employing said supplement for the treatment of obesity |
| US5466469A (en) * | 1988-06-28 | 1995-11-14 | Cibus Pharmaceutical, Inc. | Granular drug delivery system |
| DE4410238A1 (de) | 1994-03-25 | 1995-09-28 | Beiersdorf Ag | Hautpflegemittel |
| IT1275434B (it) | 1995-05-19 | 1997-08-07 | Farmila Farma Milano | Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante |
| IT1277953B1 (it) | 1995-12-21 | 1997-11-12 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per |
| CN1177807C (zh) * | 1996-05-31 | 2004-12-01 | 希格马托制药工业公司 | 稳定的、非吸湿性的l(-)肉碱和链烷酰基l(-)肉碱的盐和其制备方法以及含有此盐的固体口服组合物 |
| US5976568A (en) | 1997-02-21 | 1999-11-02 | Medical Doctors' Research Institute, Inc. | Modular system of dietary supplement compositions for optimizing health benefits and methods |
| IT1291127B1 (it) | 1997-04-01 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica |
| IT1299161B1 (it) | 1998-04-17 | 2000-02-29 | Sigma Tau Healthscience Spa | Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph |
| AU7828200A (en) * | 1999-09-23 | 2001-04-24 | Juvenon Corporation | Nutritional supplement for increased energy and stamina |
| US6562869B1 (en) | 1999-09-23 | 2003-05-13 | Juvenon, Inc. | Nutritional supplement for increased energy and stamina |
| IT1317008B1 (it) * | 2000-04-04 | 2003-05-26 | Sigma Tau Healthscience Spa | Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare. |
| JP2004515508A (ja) * | 2000-12-16 | 2004-05-27 | アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 化合物の健康促進組成物 |
| JP2004081010A (ja) * | 2002-08-22 | 2004-03-18 | Fancl Corp | 食品組成物 |
| JP2005097161A (ja) * | 2003-09-24 | 2005-04-14 | Nisshin Pharma Inc | 抗疲労用組成物およびこれを含有する食品 |
| US7169385B2 (en) * | 2003-09-29 | 2007-01-30 | Ronald G. Udell | Solubilized CoQ-10 and carnitine |
| EP1699447B1 (en) * | 2003-12-24 | 2008-09-03 | N.V. Nutricia | Compositions comprising pantothenic acid or derivatives thereof and their use for stimulating appetite |
-
2005
- 2005-10-20 US US11/253,806 patent/US8252309B2/en not_active Expired - Lifetime
-
2006
- 2006-08-21 TW TW095130679A patent/TW200803761A/zh unknown
- 2006-09-20 PT PT06793668T patent/PT1940251E/pt unknown
- 2006-09-20 PL PL06793668T patent/PL1940251T3/pl unknown
- 2006-09-20 AU AU2006303417A patent/AU2006303417A1/en not_active Abandoned
- 2006-09-20 DK DK06793668.2T patent/DK1940251T3/da active
- 2006-09-20 WO PCT/EP2006/066538 patent/WO2007045533A1/en active Application Filing
- 2006-09-20 US US12/066,625 patent/US20090257996A1/en not_active Abandoned
- 2006-09-20 JP JP2008536001A patent/JP2009512430A/ja active Pending
- 2006-09-20 AT AT06793668T patent/ATE535159T1/de active
- 2006-09-20 CA CA002622555A patent/CA2622555A1/en not_active Abandoned
- 2006-09-20 BR BRPI0617487-6A patent/BRPI0617487A2/pt not_active IP Right Cessation
- 2006-09-20 CN CNA2006800388186A patent/CN101291599A/zh active Pending
- 2006-09-20 SI SI200631270T patent/SI1940251T1/sl unknown
- 2006-09-20 RS RS20120068A patent/RS52129B/en unknown
- 2006-09-20 ES ES06793668T patent/ES2378655T3/es active Active
- 2006-09-20 EP EP06793668A patent/EP1940251B1/en active Active
- 2006-10-17 AR ARP060104514A patent/AR056129A1/es unknown
-
2012
- 2012-02-10 HR HRP20120138TT patent/HRP20120138T1/hr unknown
- 2012-02-28 CY CY20121100205T patent/CY1112660T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2622555A1 (en) | 2007-04-26 |
| CY1112660T1 (el) | 2016-02-10 |
| RS52129B (en) | 2012-08-31 |
| AU2006303417A1 (en) | 2007-04-26 |
| JP2009512430A (ja) | 2009-03-26 |
| WO2007045533A1 (en) | 2007-04-26 |
| ES2378655T3 (es) | 2012-04-16 |
| CN101291599A (zh) | 2008-10-22 |
| ATE535159T1 (de) | 2011-12-15 |
| US8252309B2 (en) | 2012-08-28 |
| SI1940251T1 (sl) | 2012-03-30 |
| PT1940251E (pt) | 2012-03-16 |
| DK1940251T3 (da) | 2012-03-19 |
| US20060057188A1 (en) | 2006-03-16 |
| AR056129A1 (es) | 2007-09-19 |
| BRPI0617487A2 (pt) | 2011-07-26 |
| PL1940251T3 (pl) | 2012-05-31 |
| EP1940251B1 (en) | 2011-11-30 |
| TW200803761A (en) | 2008-01-16 |
| US20090257996A1 (en) | 2009-10-15 |
| EP1940251A1 (en) | 2008-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20120138T1 (hr) | Energetski dodatak prehrani za skeletne mišiće i za zaštitu kardiovaskularnog sustava | |
| JP2009512430A5 (hr) | ||
| CN1074912C (zh) | 用于促进骨骼肌适应剧烈运动和对抗虚弱个体疲劳过度的营养增补剂 | |
| US7645742B2 (en) | Composition for enhancing cellular energy | |
| JP2013513398A (ja) | キレートを含むアイソトニック飲料 | |
| RU2002122099A (ru) | Пищевая добавка для увеличения мышечной массы и силы на основе альфа-липоевой кислоты | |
| RU2001116855A (ru) | Применение биохимических веществ в композиции для предотвращения и лечения болезненных состояний, вызванных сокращением клеток гладких мышц в органах человека | |
| RU2006138056A (ru) | Поливитаминные и минеральные пищевые добавки | |
| HRP20221269T1 (hr) | Pripravci za liječenje mijelofibroze | |
| JP2008531029A5 (hr) | ||
| CN103371317A (zh) | 一种核糖功能食品 | |
| CN104382892A (zh) | 增强体内一氧化氮数量和活性的组合物及其应用 | |
| AU2001270980B2 (en) | Food supplement with a slimming effect | |
| HRP20131070T1 (hr) | Uporaba alopurinola za lijeäśenje kožne reakcije na rukama i stopalima | |
| HK1109029A1 (en) | Nutritional and/or pharmaceutical preparation for use in prophylaxis and treatment of disturbances in microelements absorption from the alimentary canal | |
| CA2374333C (en) | Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract | |
| EP2227221B1 (en) | Effervescent tablets and effervescent granules containing carnitine tartrate | |
| WO2004017955A1 (en) | L-arginine containing pharmaceutical composition | |
| CA2478674A1 (en) | Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia | |
| JP2006505499A5 (hr) | ||
| CA2400959A1 (en) | Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10 | |
| ITMI20002666A1 (it) | Formulazioni alimentari ad elevato contenuto di calcio | |
| JP7353103B2 (ja) | 栄養補助組成物及びその製造方法、栄養補助組成物の不快臭の抑制方法、並びに栄養補助組成物の不快臭抑制用組成物 | |
| CN112106987A (zh) | 一种抗疲劳食品及其制备方法 | |
| CN102973543A (zh) | 一种减肥泡腾片 |